Related references
Note: Only part of the references are listed.Protein phosphatase 2A dysfunction in Alzheimer's disease
Jean-Marie Sontag et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2014)
Inhibition of calpain-regulated p35/cdk5 plays a central role in sildenafil-induced protection against chemical hypoxia produced by malonate
Lucia Barros-Minones et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Isomerase Pin1 Stimulates Dephosphorylation of Tau Protein at Cyclin-dependent Kinase (Cdk5)-dependent Alzheimer Phosphorylation Sites
Taeko Kimura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
MiR-26b, Upregulated in Alzheimer's Disease, Activates Cell Cycle Entry, Tau-Phosphorylation, and Apoptosis in Postmitotic Neurons
Sabrina Absalon et al.
JOURNAL OF NEUROSCIENCE (2013)
Tau pathology and neurodegeneration
Maria Grazia Spillantini et al.
LANCET NEUROLOGY (2013)
Deregulated Cdk5 Activity Is Involved in Inducing Alzheimer's Disease
Varsha Shukla et al.
ARCHIVES OF MEDICAL RESEARCH (2012)
Calpains - An elaborate proteolytic system
Yasuko Ono et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2012)
Phosphorylation of p35 and p39 by Cdk5 determines the subcellular location of the holokinase in a phosphorylation-site-specific manner
Akiko Asada et al.
JOURNAL OF CELL SCIENCE (2012)
Characterization of the AT180 epitope of phosphorylated Tau protein by a combined nuclear magnetic resonance and fluorescence spectroscopy approach
Laziza Amniai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
The frontotemporal dementia mutation R406W blocks tau's interaction with the membrane in an annexin A2-dependent manner
Anne Gauthier-Kemper et al.
JOURNAL OF CELL BIOLOGY (2011)
Comparative analysis of Erk phosphorylation suggests a mixed strategy for measuring phospho-form distributions
Sudhakaran Prabakaran et al.
MOLECULAR SYSTEMS BIOLOGY (2011)
Molecular Implication of PP2A and Pin1 in the Alzheimer's Disease Specific Hyperphosphorylation of Tau
Isabelle Landrieu et al.
PLOS ONE (2011)
Tau phosphorylation in hippocampus results in toxic gain-of-function
Jesus Avila et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2010)
NMR spectroscopy of the neuronal tau protein: normal function and implication in Alzheimer's disease
Isabelle Landrieu et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2010)
Membrane Association Facilitates Degradation and Cleavage of the Cyclin-Dependent Kinase 5 Activators p35 and p39
Seiji Minegishi et al.
BIOCHEMISTRY (2010)
Serine-409 phosphorylation and oxidative damage define aggregation of human protein tau in yeast
Thomas Vanhelmont et al.
FEMS YEAST RESEARCH (2010)
Current status on Alzheimer disease molecular genetics: from past, to present, to future
Karolien Bettens et al.
HUMAN MOLECULAR GENETICS (2010)
A 24-Residue Peptide (p5), Derived from p35, the Cdk5 Neuronal Activator, Specifically Inhibits Cdk5-p25 Hyperactivity and Tau Hyperphosphorylation
Ya-Li Zheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Regulation and role of cyclin-dependent kinase activity in neuronal survival and death
Shin-ichi Hisanaga et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Aβ Oligomers Cause Localized Ca2+ Elevation, Missorting of Endogenous Tau into Dendrites, Tau Phosphorylation, and Destruction of Microtubules and Spines
Hans Zempel et al.
JOURNAL OF NEUROSCIENCE (2010)
Silencing of CDK5 Reduces Neurofibrillary Tangles in Transgenic Alzheimer's Mice
Diego Piedrahita et al.
JOURNAL OF NEUROSCIENCE (2010)
The Genetics of Alzheimer Disease: Back to the Future
Lars Bertram et al.
NEURON (2010)
No difference in kinetics of tau or histone phosphorylation by CDK5/p25 versus CDK5/p35 in vitro
Dylan W. Peterson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Effect of Pin1 or Microtubule Binding on Dephosphorylation of FTDP-17 Mutant Tau
Kensuke Yotsumoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Familial FTDP-17 Missense Mutations Inhibit Microtubule Assembly-promoting Activity of Tau by Increasing Phosphorylation at Ser202 in Vitro
Dong Han et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Cyclin I activates Cdk5 and regulates expression of Bcl-2 and Bcl-XL in postmitotic mouse cells
Paul T. Brinkkoetter et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Developmental regulation of tau phosphorylation, tau kinases, and tau phosphatases
Yang Yu et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Tau phosphorylation: the therapeutic challenge for neurodegenerative disease
Diane P. Hanger et al.
TRENDS IN MOLECULAR MEDICINE (2009)
Crosstalk between Cdk5 and GSK3 beta: implications for Alzheimer's disease
Olivia Engmann et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2009)
Hyperphosphorylation of Microtubule-Associated Protein Tau: A Promising Therapeutic Target for Alzheimer Disease
C. -X. Gong et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Myristoylation of p39 and p35 is a determinant of cytoplasmic or nuclear localization of active cycline-dependent kinase 5 complexes
Akiko Asada et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3β mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing
Yi Wen et al.
JOURNAL OF NEUROSCIENCE (2008)
Kinase activities increase during the development of tauopathy in htau mice
Ian Kelleher et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Role of cyclin-dependent kinase 5 in the neurodegenerative process triggered by amyloid-beta and Prion peptides: Implications for Alzheimer's disease and Prion-related encephalopathies
Joao P. Lopes et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2007)
The prolyl isomerase PIN 1: a pivotal new twist in phosphorylation signalling and disease
Kun Ping Lu et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Cdk5 is involved in NFT-like tauopathy induced by transient cerebral ischemia in female rats
Yi Wen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2007)
Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model
Yasumasa Yoshiyama et al.
NEURON (2007)
Suppression of calpain-dependent cleavage of the CDK5 activator p35 to p25 by site-specific phosphorylation
Hirotsugu Kamei et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Extraneuronal roles of cyclin-dependent kinase 5
Jesusa L. Rosales et al.
BIOESSAYS (2006)
The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation
Florian Plattner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Cyclin-dependent protein kinase 5 primes microtubule-associated protein tau site-specifically for glycogen synthase kinase 3β
T Li et al.
BIOCHEMISTRY (2006)
Suppression of cyclin-dependent kinase 5 activation by amyloid precursor protein: A novel excitoprotective mechanism involving modulation of tau phosphorylation
P Han et al.
JOURNAL OF NEUROSCIENCE (2005)
Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease
M Kitazawa et al.
JOURNAL OF NEUROSCIENCE (2005)
Phosphorylation of FTDP-17 mutant tau by cyclin-dependent kinase 5 complexed with p35, p25, or p39
F Sakaue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Identification and isolation of a hyperphosphorylated, conformationally changed intermediate of human protein tau expressed in yeast
T Vandebroek et al.
BIOCHEMISTRY (2005)
Accumulation of filamentous tau in the cerebral cortex of human tau R406W transgenic mice
M Ikeda et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons
YL Zheng et al.
EMBO JOURNAL (2005)
Tau pathology in Alzheimer disease and other tauopathies
K Iqbal et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2005)
Transgenic animal models of tauopathies
VMY Lee et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2005)
Propentofylline attenuates tau hyperphosphorylation in Alzheimer's Swedish mutant model Tg2576
NB Chauhan et al.
NEUROPHARMACOLOGY (2005)
Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway
RA Quintanilla et al.
EXPERIMENTAL CELL RESEARCH (2004)
Early Aβ accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain
M Ingelsson et al.
NEUROLOGY (2004)
Mutant (R406W) human tau is hyperphosphorylated and does not efficiently bind microtubules in a neuronal cortical cell model
PK Krishnamurthy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The peptidyl prolyl cis/trans-isomerase Pin1 recognizes the phospho-Thr212-Pro213 site on Tau
C Smet et al.
BIOCHEMISTRY (2004)
Cdk5 deregulation in the pathogenesis of Alzheimer's disease
JC Cruz et al.
TRENDS IN MOLECULAR MEDICINE (2004)
Promotion of hyperphosphorylation by frontotemporal dementia tau mutations
AD Alonso et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Tau phosphorylation in neuronal cell function and dysfunction
GVW Johnson et al.
JOURNAL OF CELL SCIENCE (2004)
Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease:: insight from transgenic mouse and tissue-culture models
J Götz et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2004)
Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles
JC Cruz et al.
NEURON (2003)
Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration
YC Liou et al.
NATURE (2003)
Cdk5 is a key factor in tau aggregation and tangle formation in vivo
W Noble et al.
NEURON (2003)
Cyclin-dependent kinase 5 in neurofilament function and regulation
S Kesavapany et al.
NEUROSIGNALS (2003)
Multiple aspects of homocysteine neurotoxicity: Glutamate excitotoxicity, kinase hyperactivation and DNA damage
PI Ho et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2002)
Truncation of CDK5 activator p35 induces intensive phosphorylation of Ser202/Thr205 of human tau
M Hashiguchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
tau assembly in inducible transfectants expressing wild-type or FTDP-17 tau
M DeTure et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3β
F Liu et al.
FEBS LETTERS (2002)
Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau
Y Tatebayashi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Calpain-mediated cleavage of the cyclin-dependent kinase-5 activator p39 to p29
H Patzke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Structure and regulation of the CDK5-p25nck5a complex
C Tarricone et al.
MOLECULAR CELL (2001)
Involvement of cyclin dependent kinase5 activator p25 on tau phosphorylation in mouse brain
A Takashima et al.
NEUROSCIENCE LETTERS (2001)
Characterization of the in vitro phosphorylation of human tau by tau protein kinase II (cdk5/p20) using mass spectrometry
ET Lund et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Tau filament formation in transgenic mice expressing P301L tau
J Götz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Reduced binding of protein phosphatase 2A to tau protein with frontotemporal dementia and parkinsonism linked to chromosome 17 mutations
M Goedert et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein
J Lewis et al.
NATURE GENETICS (2000)
Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25
G Kusakawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Abnormal tau-containing filaments in neurodegenerative diseases
RA Crowther et al.
JOURNAL OF STRUCTURAL BIOLOGY (2000)
Neurotoxicity induces cleavage of p35 to p25 by calpain
MS Lee et al.
NATURE (2000)
Hyperphosphorylated tan and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5
MK Ahlijanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
